Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Cantor Fitzgerald
Queensland Health

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021887

« Back to Dashboard

NDA 021887 describes ALLI, which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ALLI profile page.

The generic ingredient in ALLI is orlistat. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the orlistat profile page.

Summary for 021887

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021887

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLI orlistat CAPSULE;ORAL 021887 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0461 0135-0461-08 2 BOTTLE in 1 CARTON (0135-0461-08) > 60 CAPSULE in 1 BOTTLE
ALLI orlistat CAPSULE;ORAL 021887 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0461 0135-0461-03 120 CAPSULE in 1 BOTTLE (0135-0461-03)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength60MG
Approval Date:Feb 7, 2007TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 6, 2018Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021887

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline ConsALLIorlistatCAPSULE;ORAL021887-001Feb 7, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: